IP Library Granted Patent US 8,394,937
Granted Patent B2
US 8,394,937 · App. 12/599,529 · Granted Mar 12, 2013

Expression system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,394,937
App. No.
12/599,529
Granted
Mar 12, 2013
Kind
B2
Abstract

A protein expression system is provided. The system comprises: a) a T7 RNA polymerase-dependent promoter operably linked to an expression cassette for a protein of interest; and b) an expression cassette for T7 RNA polymerase operably linked to a λpL promoter and at least two perfect palindrome operator sequences.

Claims (17)

1. A protein expression system comprising:

a) a T7 RNA polymerase-dependent promoter operably linked to an expression cassette for a protein of interest; and

b) an expression cassette for T7 RNA polymerase operably linked to a λpL promoter and at least two perfect palindrome operator sequences.

2. An expression system according to claim 1 , wherein the perfect palindrome operator sequences are selected from the group consisting of lac, gal, deo and gln.

3. An expression system according to claim 1 or 2 , wherein dual perfect palindrome operator sequences are employed.

4. An expression system according to claim 1 , wherein the T7 RNA polymerase-dependent promoter and the expression cassette for T7 RNA polymerase are located on plasmids.

5. An expression system according to claim 4 , wherein the T7 RNA polymerase-dependent promoter and the expression cassette for T7 RNA polymerase are located on separate compatible plasmids.

6. A method for the production of a protein which comprises expressing an expression system according to claim 1 .

7. A method according to claim 6 , wherein the expression occurs in an E. coli host cell.

8. A plasmid comprising an expression cassette for T7 RNA-polymerase operably linked to a λpL promoter and at least two perfect palindrome operator sequences.

9. A host cell transformed with a plasmid according to claim 8 .

10. A host cell according to claim 9 , wherein the host is E. coli.

11. A host cell according to claim 10 , wherein the host is E. coli strain B or strain K12.

12. An expression system according to claim 4 , wherein the perfect palindrome operator sequences are selected from the group consisting of lac, gal, deo and gln.

13. An expression system according to claim 12 , wherein dual perfect palindrome operator sequences are employed.

14. The method of claim 7 , wherein the E. coli host cell is a B strain.

15. The method of claim 7 , wherein the E. coli host cell is a K12 strain.

Assignments (3)
CHANGE OF NAME Recorded Aug 2, 2011
From: MSD BIOLOGICS (UK) LIMITED
To: FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED
Reel/Frame 026685/0677 →
CHANGE OF NAME Recorded Nov 9, 2010
From: AVECIA BIOLOGICS LIMITED
To: MSD BIOLOGICS (UK) LIMITED
Reel/Frame 025416/0961 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2009
From: KARA, BHUPENDRA VALLABH; HODGSON, IAN JOHN
To: AVECIA BIOLOGICS LIMITED
Reel/Frame 023494/0492 →